Literature DB >> 10654668

Structure and function of dopamine receptors.

D Vallone1, R Picetti, E Borrelli.   

Abstract

Dopamine (DA) is the most abundant catecholamine in the brain. The involvement and importance of DA as a neurotransmitter in the regulation of different physiological functions in the central nervous system (CNS) is well known. Deregulation of the dopaminergic system has been linked with Parkinson's disease, Tourette's syndrome, schizophrenia, attention deficit hyperactive disorder (ADHD) and generation of pituitary tumours. This review focuses on the pharmacological and biochemical features shared by the dopamine receptors. We address their coupling to secondary messenger pathways and their physiological function based upon studies using pharmacological tools, specific brain lesions and, more recently, genetically modified animal models.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10654668     DOI: 10.1016/s0149-7634(99)00063-9

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  190 in total

1.  Dopaminergic reward system: a short integrative review.

Authors:  Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal:  Int Arch Med       Date:  2010-10-06

2.  Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders.

Authors:  Mohammad-Reza Noori-Daloii; Majid Mojarrad; Ali Rashidi-Nezhad; Majid Kheirollahi; Ali Shahbazi; Mehdi Khaksari; Asghar Korzebor; Ali Goodarzi; Maryam Ebrahimi; Ali Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

3.  Juvenile hormone synthesis is stimulated by activation of dopamine D1-like receptors in Drosophila.

Authors:  I Y Rauschenbach; E K Karpova; E V Bogomolova; O V Laukhina; N E Gruntenko
Journal:  Dokl Biochem Biophys       Date:  2012-01-06       Impact factor: 0.788

4.  Light increases the gap junctional coupling of retinal ganglion cells.

Authors:  Edward H Hu; Feng Pan; Béla Völgyi; Stewart A Bloomfield
Journal:  J Physiol       Date:  2010-11-01       Impact factor: 5.182

5.  PharmGKB summary: dopamine receptor D2.

Authors:  Huaiyu Mi; Paul D Thomas; Huijun Z Ring; Ruhong Jiang; Katrin Sangkuhl; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-06       Impact factor: 2.089

6.  Activation of D2-like dopamine receptors inhibits young hormone degradation in female Drosophila.

Authors:  E K Karpova; I Yu Rauschenbach; L V Shchumnaya; N E Gruntenko
Journal:  Dokl Biol Sci       Date:  2010-06-22

Review 7.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

8.  The effect of dopamine on alkaline phosphatase activity in Drosophila is mediated by D2-like receptors.

Authors:  E V Bogomolova; I Yu Rauschenbach; A A Alekseev; N V Faddeev; N E Gruntenko
Journal:  Dokl Biochem Biophys       Date:  2010 Mar-Apr       Impact factor: 0.788

9.  Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study.

Authors:  Robert H Mach; Zhude Tu; Jinbin Xu; Shihong Li; Lynne A Jones; Michelle Taylor; Robert R Luedtke; Colin P Derdeyn; Joel S Perlmutter; Mark A Mintun
Journal:  Synapse       Date:  2011-03-21       Impact factor: 2.562

Review 10.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.